Skip navigation

Posters supplementary informations

Contents

Thank you for your interest. You will find on this webpage supplementary informations for various posters and presentations

A yeast functional screen predicts new candidate ALS disease genes.

Abstract

ALS is a devastating adult-onset neurodegenerative disease that attacks upper and lower motor neurons. Symptoms of this disease are a progressive and fatal muscle paralysis, causing death within 2 to 5 years of disease onset.
Mutations in several genes have been linked to both sporadic or familial forms of ALS, including SOD1, TARDBP, FUS/TLS and others. Two of these genes, TARDBP (TDP-43) and FUS/TLS (FUS) both encode similar types of RNA-binding proteins and have been identified as components of pathological inclusions in neurons of ALS patients. An emerging concept suggested by the discoveries of FUS and TDP-43 in ALS is that defects in RNA metabolism might contribute to the pathogenesis.

Poster and supplementary informations

A yeast functional screen predicts new ALS disease genes

High-throughput targeted sequencing to assess the role of RNA-binding proteins in ALS.

Abstract

ALS is a devastating adult-onset neurodegenerative disease that attacks upper and lower motor neurons. Symptoms of this disease are a progressive and fatal muscle paralysis, causing death within 2 to 5 years of disease onset.
Mutations in several genes have been linked to both sporadic or familial forms of ALS, including SOD1, TARDBP, FUS/TLS and others. Two of these genes, TARDBP (TDP-43) and FUS/TLS (FUS) both encode similar types of RNA-binding proteins and have been identified as components of pathological inclusions in neurons of ALS patients. An emerging concept suggested by the discoveries of FUS and TDP-43 in ALS is that defects in RNA metabolism might contribute to the pathogenesis.

Poster and supplementary informations

High-throughput targeted sequencing to assess the role of RNA-binding proteins in ALS

Contact

For more informations you can contact me by email. More options available on my contact informations page.